Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Poniard Pharmaceuticals' Gamble Doesn't Pay Off
Seeking Alpha
Thursday, November 19, 2009 - 10:29am
tags:
Poniard, picoplatin
U.S. Sees Low Demand for BioCryst Flu Drug
TheStreet.com
Thursday, November 19, 2009 - 10:28am
tags:
Flu, Biocryst, peramivir
Genzyme Drops Kidney-Drug Plans Amid Pileup of Bad News
WSJ Online
Thursday, November 19, 2009 - 10:23am
tags:
Pompe disease, Genzyme
Should You Buy It? Alkermes
TheStreet.com
Thursday, November 19, 2009 - 9:58am
tags:
Alkermes
Flu Shot Made From Caterpillars May Win Pivotal U.S. Backing
Bloomberg
Thursday, November 19, 2009 - 9:56am
tags:
FluBlok, Flu, vaccines, Protein Biosciences
J&J vs. 10-Year T-Bonds: The Power of Rising Dividends
Seeking Alpha
Thursday, November 19, 2009 - 9:53am
tags:
JNJ
Drug Lowers Cholesterol; Stock Follows
Motley Fool
Thursday, November 19, 2009 - 9:13am
tags:
Isis Pharmaceuticals, cholesterol, mipomersen
Hard to Get Excited about BI's Flibanserin
InVivo
Thursday, November 19, 2009 - 9:09am
tags:
Boehringer Ingelheim, flibanserin, sexual dysfunction
U.S. panel rejects Xolair asthma drug for children
Reuters
Thursday, November 19, 2009 - 9:08am
tags:
Xolair, asthma, FDA, Roche, Novartis
Sanofi-Aventis to launch antimalarial drug study
Marketwatch
Thursday, November 19, 2009 - 9:07am
tags:
Sanofi, antimalarial, ASAQ
AstraZeneca submits Brilinta NDA to FDA
Marketwatch
Thursday, November 19, 2009 - 9:06am
tags:
NDA, FDA, Brilinta, AstraZeneca
Genentech, Biogen Idec get FDA request on application for Rituxan's use in leukemia
Yahoo/AP
Thursday, November 19, 2009 - 7:52am
tags:
Genentech, Roche, Biogen Idec, FDA, Rituxan, leukemia
Obesity and ED: Two Big Markets, One Tiny Company
Minyanville
Thursday, November 19, 2009 - 7:50am
tags:
obesity, erectile dysfunction, Revive, Qnexa
Pfizer to Begin Selling Generics in Japan
TheStreet.com
Thursday, November 19, 2009 - 7:49am
tags:
Pfizer, generics, Japan
AstraZeneca May Face 6,000 Seroquel Trials as Judge to Urge Cases' Return
Bloomberg
Thursday, November 19, 2009 - 6:41am
tags:
AstraZeneca, Seroquel, diabetes, lawsuits
Drugmaker Reinvents Itself And Expands Footprint Internationally
Yahoo/Investors Business Daily
Thursday, November 19, 2009 - 6:40am
tags:
Valeant Pharmaceuticals, GSK
Four Healthcare Stocks On Fire
Investopedia
Thursday, November 19, 2009 - 6:38am
tags:
Novartis, Exelixis, Bristol-Myers Squibb, Sanofi, Intuitive Surgical
FDA panel backs Pfizer's enhanced vaccine for kids
Yahoo/AP
Thursday, November 19, 2009 - 6:37am
tags:
Pfizer, vaccines, pneumococcal disease, FDA, Panel, Prevnar
On the Radar: November's biotech stocks to watch
Fierce Biotech
Wednesday, November 18, 2009 - 12:17pm
tags:
biotech, Cadence Pharmaceuticals, Micromet, Momenta, Pharmasset, Protalix BioTherapeutics
Crestor shines, Vitamin D intrigues at AHA confab
Fierce Pharma
Wednesday, November 18, 2009 - 12:14pm
tags:
AHA, Crestor, AstraZeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.